^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Title:

Pan-Asian adaptation of the EHNSeESMOeESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

Excerpt:
Recommendation 3: Treatment...In patients unfit for cisplatin, carboplatin combined with 5-FU or cetuximab concomitant to RT as well as hyperfractionated or accelerated RT without chemotherapy are treatment alternatives [II, A].
DOI:
https://doi.org/10.1016/j.esmoop.2021.100309